C M Bidwell & Associates LTD Corcept Therapeutics Inc Transaction History

C M Bidwell & Associates LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $101,193 - $155,682	4,606 New	4,606 $125,000
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $227,768 - $365,234	-18,280 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $201,080 - $333,792	18,280 New	18,280 $307,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $37,508 - $52,088	-3,710 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$12.06 - $16.96 $44,742 - $62,921	3,710 New	3,710 $45,000

361

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.